268 related articles for article (PubMed ID: 32878893)
1. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of varicella zoster virus pathogenesis.
Zerboni L; Sen N; Oliver SL; Arvin AM
Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
[TBL] [Abstract][Full Text] [Related]
3. H84T BanLec has broad spectrum antiviral activity against human herpesviruses in cells, skin, and mice.
Lloyd MG; Liu D; Legendre M; Markovitz DM; Moffat JF
Sci Rep; 2022 Jan; 12(1):1641. PubMed ID: 35102178
[TBL] [Abstract][Full Text] [Related]
4. Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.
François S; Sen N; Mitton B; Xiao X; Sakamoto KM; Arvin A
J Virol; 2016 Oct; 90(19):8686-97. PubMed ID: 27440893
[TBL] [Abstract][Full Text] [Related]
5. Autophagic flux without a block differentiates varicella-zoster virus infection from herpes simplex virus infection.
Buckingham EM; Carpenter JE; Jackson W; Zerboni L; Arvin AM; Grose C
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):256-61. PubMed ID: 25535384
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
Zerboni L; Reichelt M; Arvin A
Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
[TBL] [Abstract][Full Text] [Related]
7. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
De C; Liu D; Zheng B; Singh US; Chavre S; White C; Arnold RD; Hagen FK; Chu CK; Moffat JF
Antiviral Res; 2014 Oct; 110():10-9. PubMed ID: 25051026
[TBL] [Abstract][Full Text] [Related]
8. Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.
Lloyd MG; Yee MB; Flot JS; Liu D; Geiler BW; Kinchington PR; Moffat JF
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458556
[TBL] [Abstract][Full Text] [Related]
9. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.
Zerboni L; Arvin A
PLoS Pathog; 2015 Jun; 11(6):e1004989. PubMed ID: 26090802
[TBL] [Abstract][Full Text] [Related]
10. Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
Zerboni L; Sung P; Lee G; Arvin A
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563288
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
[TBL] [Abstract][Full Text] [Related]
12. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
Majima R; Shindoh K; Yamaguchi T; Inoue N
Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
[TBL] [Abstract][Full Text] [Related]
15. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
16. A SCID mouse-human lung xenograft model of varicella-zoster virus infection.
Wang W; Pan D; Fu W; Cai L; Ye J; Liu J; Liu C; Huang X; Lin Y; Xia N; Cheng T; Zhu H
Antiviral Res; 2017 Oct; 146():45-53. PubMed ID: 28827121
[TBL] [Abstract][Full Text] [Related]
17. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
18. Replication of varicella-zoster virus in human skin organ culture.
Taylor SL; Moffat JF
J Virol; 2005 Sep; 79(17):11501-6. PubMed ID: 16103201
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox.
Annunziato PW; Lungu O; Panagiotidis C; Zhang JH; Silvers DN; Gershon AA; Silverstein SJ
J Virol; 2000 Feb; 74(4):2005-10. PubMed ID: 10644373
[TBL] [Abstract][Full Text] [Related]
20. Humanized Severe Combined Immunodeficient (SCID) Mouse Models for Varicella-Zoster Virus Pathogenesis.
Lloyd MG; Moffat JF
Curr Top Microbiol Immunol; 2023; 438():135-161. PubMed ID: 35292858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
